Kovack Advisors Inc. Grows Stock Position in GE HealthCare Technologies Inc. $GEHC

Kovack Advisors Inc. grew its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 35.5% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 4,369 shares of the company’s stock after buying an additional 1,144 shares during the quarter. Kovack Advisors Inc.’s holdings in GE HealthCare Technologies were worth $324,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in GEHC. JPMorgan Chase & Co. lifted its position in shares of GE HealthCare Technologies by 49.9% in the first quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock valued at $414,894,000 after acquiring an additional 1,711,963 shares in the last quarter. Nuveen LLC purchased a new position in shares of GE HealthCare Technologies in the first quarter valued at approximately $77,058,000. Eminence Capital LP lifted its position in shares of GE HealthCare Technologies by 38.7% in the first quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock valued at $146,822,000 after acquiring an additional 507,101 shares in the last quarter. Homestead Advisers Corp lifted its position in shares of GE HealthCare Technologies by 92.7% in the first quarter. Homestead Advisers Corp now owns 988,600 shares of the company’s stock valued at $79,790,000 after acquiring an additional 475,500 shares in the last quarter. Finally, Canada Pension Plan Investment Board lifted its position in shares of GE HealthCare Technologies by 15.2% in the first quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock valued at $251,121,000 after acquiring an additional 409,636 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $74.95 on Monday. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. The company has a market capitalization of $34.14 billion, a P/E ratio of 15.49, a P/E/G ratio of 2.82 and a beta of 1.13. The stock’s fifty day moving average is $75.09 and its two-hundred day moving average is $73.14.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The company had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. During the same quarter in the previous year, the business earned $1.14 earnings per share. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be given a $0.035 dividend. The ex-dividend date is Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 2.89%.

Analyst Ratings Changes

GEHC has been the topic of several research reports. Barclays began coverage on GE HealthCare Technologies in a research report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 target price on the stock. Morgan Stanley lifted their price objective on GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Thursday. BTIG Research set a $87.00 price objective on GE HealthCare Technologies in a research report on Wednesday. Evercore ISI lifted their price objective on GE HealthCare Technologies from $88.00 to $92.00 and gave the stock an “outperform” rating in a research report on Thursday. Finally, Citigroup downgraded GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $93.00 to $83.00 in a research report on Tuesday, October 7th. Six analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $86.10.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.